Loading...
Header Logo
Keywords
Last Name

Robert P. Schwartz, M.D.

TitleProfessor Emeritus
InstitutionWake Forest School of Medicine
DepartmentPediatrics-Endocrinology
Address
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    U10DA013034     (STITZER, MAXINE L)Sep 30, 1999 - Aug 31, 2015
    NIH/NIDA
    Clinical Trials Network Mid-Atlantic Collaborative Group
    Role: Co-Principal Investigator

    R01DA013636     (SCHWARTZ, ROBERT P)Jan 1, 2001 - May 31, 2012
    NIH/NIDA
    Entry Into Comprehensive Methadone Treatment Via Interim Maintenance
    Role: Principal Investigator

    U01DA013636     (SCHWARTZ, ROBERT P)Jan 1, 2001 - May 31, 2017
    NIH/NIDA
    A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail
    Role: Principal Investigator

    R01DA015842     (SCHWARTZ, ROBERT P)Jun 15, 2004 - May 31, 2010
    NIH/NIDA
    Re-engineering Methadone Treatment: A Randomized Clinical Trial
    Role: Principal Investigator

    R01DA026003     (SCHWARTZ, ROBERT P)Sep 30, 2009 - Jul 31, 2014
    NIH/NIDA
    SBIRT in New Mexico
    Role: Principal Investigator

    UG1DA013034     (BIGELOW, GEORGE)Sep 1, 2018 - May 31, 2020
    NIH/NIDA
    Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative
    Role: Co-Principal Investigator

    R01DA046910     (SCHWARTZ, ROBERT P)Sep 30, 2018 - Jul 31, 2022
    NIH/NIDA
    Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
    Role: Principal Investigator

    U01DA046910     (SCHWARTZ, ROBERT P)Sep 30, 2018 - Jul 31, 2022
    NIH/NIDA
    Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
    Role: Principal Investigator

    U01DA047982     (LEE, JOSHUA D)Aug 1, 2019 - Apr 30, 2024
    NIH/NIDA
    Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Gandhi D, Olsen Y, Jaffe JH. Patient-centered methadone treatment: a randomized clinical trial. Addiction. 2017 03; 112(3):454-464. PMID: 27661788.
      View in: PubMed
    2. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97]. Contemp Clin Trials. 2016 11; 51:98. PMID: 27665683.
      View in: PubMed
    3. McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, Sleiter L, Russell L, Nordeck C, Sharma A, O'Grady KE, Bouk LB, Cushing C, King J, Wahle A, Schwartz RP. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 2016 Nov 15; 165(10):690-699. PMID: 27595276.
      View in: PubMed
    4. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool. Contemp Clin Trials. 2016 09; 50:90-7. PMID: 27444426.
      View in: PubMed
    5. Resnicow K, Harris D, Wasserman R, Schwartz RP, Perez-Rosas V, Mihalcea R, Snetselaar L. Advances in Motivational Interviewing for Pediatric Obesity: Results of the Brief Motivational Interviewing to Reduce Body Mass Index Trial and Future Directions. Pediatr Clin North Am. 2016 06; 63(3):539-62. PMID: 27261549.
      View in: PubMed
    6. Ip EH, Leng X, Zhang Q, Schwartz R, Chen SH, Dai S, Labarthe D. Risk profiles of lipids, blood pressure, and anthropometric measures in childhood and adolescence: project heartBeat! BMC Obes. 2016; 3:9. PMID: 26929822.
      View in: PubMed
    7. Contreras JJ, Hiestand B, O'Neill JC, Schwartz R, Nadkarni M. Vitamin D deficiency in children with fractures. Pediatr Emerg Care. 2014 Nov; 30(11):777-81. PMID: 25343741.
      View in: PubMed
    8. Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos JM, Silverman K. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial. Prev Med. 2014 Nov; 68:62-70. PMID: 24607365.
      View in: PubMed
    9. Kinlock TW, Gordon MS, Schwartz RP, O'Grady KE. Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment. J Offender Rehabil. 2013 Oct; 52(8):509-528. PMID: 25580067.
      View in: PubMed
    10. Schwartz RP, Vitolins MZ, Case LD, Armstrong SC, Perrin EM, Cialone J, Bell RA. The YMCA Healthy, Fit, and Strong Program: a community-based, family-centered, low-cost obesity prevention/treatment pilot study. Child Obes. 2012 Dec; 8(6):577-82. PMID: 23181924.
      View in: PubMed
    11. Mitchell SG, Gryczynski J, Gonzales A, Moseley A, Peterson T, O'Grady KE, Schwartz RP. Screening, brief intervention, and referral to treatment (SBIRT) for substance use in a school-based program: services and outcomes. Am J Addict. 2012 Nov; 21 Suppl 1:S5-13. PMID: 23786511.
      View in: PubMed
    12. Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O'Brien CP. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus. 2012; 33(1):48-59. PMID: 22263713.
      View in: PubMed
    13. Schwartz RP. Motivational interviewing (patient-centered counseling) to address childhood obesity. Pediatr Ann. 2010 Mar; 39(3):154-8. PMID: 20302247.
      View in: PubMed
    14. Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT. Developing and Implementing a New Prison-Based Buprenorphine Treatment Program. J Offender Rehabil. 2010 Feb; 49(2):91-109. PMID: 20473351.
      View in: PubMed
    15. Katz EC, Schwartz RP, King S, Highfield DA, O'Grady KE, Billings T, Gandhi D, Weintraub E, Glovinsky D, Barksdale W, Brown BS. Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes. Am J Drug Alcohol Abuse. 2009; 35(2):63-7. PMID: 19199166.
      View in: PubMed
    16. Schwartz RP, Hamre R, Dietz WH, Wasserman RC, Slora EJ, Myers EF, Sullivan S, Rockett H, Thoma KA, Dumitru G, Resnicow KA. Office-based motivational interviewing to prevent childhood obesity: a feasibility study. Arch Pediatr Adolesc Med. 2007 May; 161(5):495-501. PMID: 17485627.
      View in: PubMed
    17. Schwartz RP. Super-size kids' meals lead to super-size kids. N C Med J. 2002 Nov-Dec; 63(6):305-7. PMID: 12970980.
      View in: PubMed
    Schwartz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _